+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cell Isolation Market 2019-2023 - Product Image

Global Cell Isolation Market 2019-2023

  • ID: 4772988
  • Report
  • May 2019
  • Region: Global
  • 130 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Merck KGaA
  • QIAGEN NV
  • MORE
The rise in demand for clinical diagnosis is one of the key factors anticipated to drive the cell isolation market growth during the forecast period. To effectively treat various diseases using genetic engineering tools, early diagnosis is essential. Genetic engineering tools provide diagnostic enzymes such as cholesterol oxidase and xylitol oxidase. These diagnostic enzymes identify specific cells like cells with high levels of cholesterol. When blood levels of these particular enzymes increase significantly, it indicates a probable site for tissue damage, which releases these enzymes in the blood. These enzymes are used in assays using samples of serum or urine. The isolation of these enzymes can provide the required enzymes for clinical diagnosis. Thus, genetic engineering tools are useful, precise, and economical for researchers and healthcare providers to diagnose patients. Analysts have predicted that the cell isolation market will register a CAGR of almost 19% by 2023.

Market Overview

Increasing prevalence of chronic diseases

The growing incidences of chronic diseases have increased the need for cell-based therapies. Cell isolation is an important step in various experiments during diagnostics and research of chronic diseases. Cell isolation tools are increasingly used in drug discovery techniques to generate recombinant protein therapeutics, which can treat a variety of diseases, including cancer, autoimmune diseases, and genetic disorders. The wide applications of isolated human cells in research, drug development, and clinical trials are increasing with growing incidences of chronic diseases globally. Hence, the rising prevalence of chronic diseases increases the demand for cell-based therapies, which increases the demand for cell isolation tools.

Ethical issues regarding embryonic stem cell isolation

The high potential of stem cell-based therapy in clinical applications has encouraged researchers to use stem cell tools to treat genetic disorders in pharmacy genomics and regenerative medicines. However, clinical applications of stem cells raise some ethical and safety concerns regarding the extraction of human embryonic stem cells. The key issue lies with the destruction of a human embryo, which impedes the development of human embryonic stem cell-based clinical therapies.

Competitive Landscape

The market appears to be fairly fragmented. The presence of several companies, including Agilent Technologies Inc. and Becton Dickinson and Co., makes the competitive environment quite intense. Several vendors are expected to participate in such strategic alliances to gain a competitive advantage, which will improve the availability of cell isolation products in the market. Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Merck KGaA
  • QIAGEN NV
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Consumables - Market size and forecast 2018-2023
  • Instruments - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER
  • Market segmentation by end-user
  • Comparison by end-user
  • AR - Market size and forecast 2018-2023
  • PB - Market size and forecast 2018-2023
  • CRO - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user
PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Product advances
  • Growing adoption of genetic engineering in forensic research
  • Strategic alliances
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Merck KGaA
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: EXPLORE

List of Exhibits:
Exhibit 01: Global healthcare market
Exhibit 02: Segments of global healthcare market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Consumables - Year-over-year growth 2019-2023 (%)
Exhibit 21: Instruments - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Instruments - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: End-user - Market share 2018-2023 (%)
Exhibit 26: Comparison by end-user
Exhibit 27: AR - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: AR - Year-over-year growth 2019-2023 (%)
Exhibit 29: PB - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: PB - Year-over-year growth 2019-2023 (%)
Exhibit 31: CRO - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: CRO - Year-over-year growth 2019-2023 (%)
Exhibit 33: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Others - Year-over-year growth 2019-2023 (%)
Exhibit 35: Market opportunity by end-user
Exhibit 36: Market share by geography 2018-2023 (%)
Exhibit 37: Geographic comparison
Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: North America - Year-over-year growth 2019-2023 (%)
Exhibit 40: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 42: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 44: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 45: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 46: Key leading countries
Exhibit 47: Market opportunity
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendors covered
Exhibit 52: Vendor classification
Exhibit 53: Market positioning of vendors
Exhibit 54: Agilent Technologies Inc. - Vendor overview
Exhibit 55: Agilent Technologies Inc. - Business segments
Exhibit 56: Agilent Technologies Inc. - Organizational developments
Exhibit 57: Agilent Technologies Inc. - Geographic focus
Exhibit 58: Agilent Technologies Inc. - Segment focus
Exhibit 59: Agilent Technologies Inc. - Key offerings
Exhibit 60: Becton Dickinson and Co. - Vendor overview
Exhibit 61: Becton Dickinson and Co. - Business segments
Exhibit 62: Becton Dickinson and Co. - Organizational developments
Exhibit 63: Becton Dickinson and Co. - Geographic focus
Exhibit 64: Becton Dickinson and Co. - Segment focus
Exhibit 65: Becton Dickinson and Co. - Key offerings
Exhibit 66: Merck KGaA - Vendor overview
Exhibit 67: Merck KGaA - Business segments
Exhibit 68: Merck KGaA - Organizational developments
Exhibit 69: Merck KGaA - Geographic focus
Exhibit 70: Merck KGaA - Segment focus
Exhibit 71: Merck KGaA - Key offerings
Exhibit 72: QIAGEN NV - Vendor overview
Exhibit 73: QIAGEN NV - Product segments
Exhibit 74: QIAGEN NV - Organizational developments
Exhibit 75: QIAGEN NV - Geographic focus
Exhibit 76: QIAGEN NV - Segment focus
Exhibit 77: QIAGEN NV - Key offerings
Exhibit 78: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 79: Thermo Fisher Scientific Inc. - Product segments
Exhibit 80: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 81: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 82: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 83: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Merck KGaA
  • QIAGEN NV
  • MORE
The analyst recognizes the following companies as the key players in the global cell isolation market: Agilent Technologies Inc., Becton Dickinson and Co., Merck KGaA, QIAGEN NV, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the growing adoption of genetic engineering in forensic research.”

According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.

Further, the report states that one of the major factors hindering the growth of this market is the lack of trained laboratory professionals.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Agilent Technologies Inc.
  • Becton Dickinson and Co.
  • Merck KGaA
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown
Adroll
adroll